SubscribeLogin
Published

Healthcare’s Golden Age: Four investment experts identify eight healthcare investments beyond obesity drugs - IFA Magazine

Summary by IFA Magazine
While blockbuster obesity drugs have dominated news headlines this year, ground-breaking innovations are taking place across the healthcare sector and catching the attention of investors. Darius McDermott, managing director at FundCalibre, highlights the seismic advancements shaping 2024: “We’re witnessing a revolution in the treatment of obesity, with the NHS now starting trials of weight-loss drug Mounjaro. In the same week, scientists announc…
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

HealthcareHealthcare
Novo NordiskNovo Nordisk
United KingdomUnited Kingdom
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal